New York Stock Exchange · ABBV
AbbVie Inc. price
Price history, key statistics, and comparable assets for AbbVie Inc..
$246.04
+0.89% ($2.17)
Historical prices
Price history
Intraday through long-term closing prices. Choose 1 day, 1 week, 1 month, 6 months, year to date, 1 year, 5 years, or all available history.
Point-in-time fields
Key statistics
- Previous close
- $243.87
- Open
- $243.62
- Day range
- $241.99 to $246.76
- 52-week range
- $190.75 to $267.47
- Volume
- 4.7M
- Average volume
- 6.19M
- Market cap
- 434.78B
- P/E ratio (TTM)
- 69.57
Profile
About AbbVie Inc.
AbbVie Inc. trades on New York Stock Exchange under ABBV and is grouped under Health Technology. Figures marked unavailable are not estimated.
Editorial profile
AbbVie Inc. overview
AbbVie Inc. researches and commercializes medicines in immunology, oncology, neuroscience, eye care, and other therapeutic areas. The group also includes Allergan Aesthetics products and related medical-aesthetics services. These activities place the company in Health Technology and connect ABBV to the specific products, services, customers, and operating assets described in its official materials.
SourcesAbbVie Inc.ABBV is the common stock quoted on New York Stock Exchange. AbbVie Inc.'s investor materials publish quarterly results and an annual report. This profile refers to that local security and operating group, which matters when an issuer has several venues, share classes, depositary receipts, or a name that resembles another company.
SourcesAbbVie Inc.AbbVie Inc.A genuinely distinguishing feature is that AbbVie combines prescription biopharmaceutical franchises with an aesthetics portfolio that includes Botox Cosmetic and facial products. That mix spans therapeutic medicines and physician-administered aesthetics within one company. This is more precise than a broad sector label: it identifies a named platform, product architecture, network, asset base, or corporate structure that separates AbbVie Inc. from otherwise similar issuers.
SourcesAbbVie Inc.- Security type
- Common Stock
Primary sources
- AbbVie Inc. official company profileAbbVie Inc. · Retrieved 2026-08-10
- AbbVie Inc. investor relationsAbbVie Inc. · Retrieved 2026-08-10
- ABBV listing informationAbbVie Inc. · Retrieved 2026-08-10
Contextual peers
Related assets
ABBV questions
AbbVie Inc. questions
What business does ABBV represent?
ABBV represents AbbVie Inc., which researches and commercializes medicines in immunology, oncology, neuroscience, eye care, and other therapeutic areas. The group also includes Allergan Aesthetics products and related medical-aesthetics services.
Which products, services, or operating markets are specifically associated with ABBV?
The group also includes Allergan Aesthetics products and related medical-aesthetics services.
What specifically distinguishes the business behind ABBV?
For AbbVie Inc., the asset-specific distinction is that AbbVie combines prescription biopharmaceutical franchises with an aesthetics portfolio that includes Botox Cosmetic and facial products. That mix spans therapeutic medicines and physician-administered aesthetics within one company.
Risk and data disclosure
Read before using this data
Glide provides this market data for informational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any asset. Prices may be delayed or incomplete. Verify market data and consider your objectives, financial situation, and professional advice before acting.